a Department of Breast Surgery , Hubei Cancer Hospital , Wuhan , China.
b Department of Surgery , Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA.
Cancer Biol Ther. 2018;19(10):858-868. doi: 10.1080/15384047.2018.1456599. Epub 2018 Apr 30.
Distant metastasis accounts for the vast majority of deaths in patients with cancer. Breast cancer exhibits a distinct metastatic pattern commonly involving bone, liver, lung, and brain. Breast cancer can be divided into different subtypes based on gene expression profiles, and different breast cancer subtypes show preference to distinct organ sites of metastasis. Luminal breast tumors tend to metastasize to bone while basal-like breast cancer (BLBC) displays a lung tropism of metastasis. However, the mechanisms underlying this organ-specific pattern of metastasis still remain to be elucidated. In this review, we will summarize the recent advances regarding the molecular signaling pathways as well as the therapeutic strategies for treating breast cancer lung metastasis.
远处转移是癌症患者死亡的主要原因。乳腺癌具有独特的转移模式,通常涉及骨、肝、肺和脑。乳腺癌可以根据基因表达谱分为不同亚型,不同的乳腺癌亚型对不同的转移器官部位具有倾向性。腔面型乳腺癌倾向于转移至骨,而基底样乳腺癌(BLBC)则表现出肺转移的倾向。然而,这种器官特异性转移模式的机制仍有待阐明。在这篇综述中,我们将总结关于治疗乳腺癌肺转移的分子信号通路以及治疗策略的最新进展。